T1	LIVB 21 26	Mujer
#1	AnnotatorNotes T1	C0043210; Woman; Population Group | C0242665; wife; Family Group
T2	Age 30 37	65 años
T3	DISO 52 60	erupción
#2	AnnotatorNotes T3	C0015230; Exanthema; Sign or Symptom | C0302295; Eruptions; Pathologic Function
T4	Neg_cue 65 67	no
T5	Negated 68 78	desaparece
T6	Neg_cue 130 132	No
T7	DISO 133 156	alergias medicamentosas
#3	AnnotatorNotes T7	C0013182; Drug Allergy; Pathologic Function
T8	Negated 133 166	alergias medicamentosas conocidas
T9	DISO 170 182	Intolerancia
T10	CHEM 185 196	clavulánico
T11	DISO 198 205	diarrea
#4	AnnotatorNotes T11	C0011991; Diarrhea; Sign or Symptom
T12	CHEM 209 218	enalapril
#5	AnnotatorNotes T12	C0014025; enalapril; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T13	DISO 220 223	tos
#6	AnnotatorNotes T13	C0010200; Coughing; Sign or Symptom
T14	DISO 228 238	Exfumadora
#7	AnnotatorNotes T14	C0337671; Former smoker; Finding
T15	Frequency 257 263	al día
T16	Duration 272 279	40 años
T17	Frequency 292 296	/año
T18	Neg_cue 301 303	No
T19	DISO 304 323	bebedora de alcohol
T20	Negated 304 323	bebedora de alcohol
T21	DISO 327 335	Obesidad
#8	AnnotatorNotes T21	C0028754; Obesity; Disease or Syndrome
T22	PROC 354 357	IMC
T23	DISO 366 387	Hipertensión arterial
#9	AnnotatorNotes T23	C0020538; Hypertensive disease; Disease or Syndrome
T24	DISO 391 403	Enfermedades
#10	AnnotatorNotes T24	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T25	DISO 413 422	neurolúes
T26	DISO 424 443	vasculitis cerebral
T27	DISO 457 482	trombosis venosa superior
T28	DISO 487 514	afectación del área macular
T29	DISO 516 527	gonartrosis
#11	AnnotatorNotes T29	C0877389; Gonarthrosis; Disease or Syndrome
T30	PROC 531 557	Intervenciones quirúrgicas
#12	AnnotatorNotes T30	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T31	PROC 559 573	apendicectomía
#13	AnnotatorNotes T31	C0003611; Appendectomy; Therapeutic or Preventive Procedure
T32	PROC 575 582	cesárea
#14	AnnotatorNotes T32	C0007876; Cesarean section; Therapeutic or Preventive Procedure
T33	PROC 584 597	histerectomía
#15	AnnotatorNotes T33	C0020699; Hysterectomy; Therapeutic or Preventive Procedure
T34	Date 599 603	1999
T35	PROC 606 620	cirugía ocular
#16	AnnotatorNotes T35	C0395020; Surgical procedure on eye proper; Therapeutic or Preventive Procedure
T36	DISO 622 643	carcinoma basocelular
#17	AnnotatorNotes T36	C0007117; Basal cell carcinoma; Neoplastic Process
T37	ANAT 644 665	región axilar derecha
T38	Date 667 671	2015
T39	PROC 676 700	Tratamiento domiciliario
T40	CHEM 702 710	Losartán
#18	AnnotatorNotes T40	C0126174; losartan; Organic Chemical · Pharmacologic Substance
T41	Dose 711 731	100 mg (1 comprimido
T42	Frequency 732 745	cada 24 horas
T43	DISO 751 761	Enfermedad
#19	AnnotatorNotes T43	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T44	Date 762 768	actual
T45	DISO 791 819	erupción cutánea pruriginosa
T46	ANAT 826 832	tronco
#20	AnnotatorNotes T46	C0460005; Trunk structure; Body Location or Region | C1280632; Entire trunk; Body Part, Organ, or Organ Component
T47	Duration 836 841	meses
T48	Neg_cue 856 858	No
T49	Negated 878 910	cambios en los productos de aseo
T50	Neg_cue 912 914	No
T51	Negated 915 934	otra sintomatología
T52	DISO 920 934	sintomatología
#21	AnnotatorNotes T52	C3540840; Sign or Symptom; Finding
T53	PROC 961 979	Exploración física
#22	AnnotatorNotes T53	C0031809; Physical Examination; Health Care Activity
T54	PROC 1006 1032	Exploración cardiopulmonar
T55	DISO 1043 1081	Lesiones eritematosas de color intenso
T56	DISO 1140 1151	descamación
#23	AnnotatorNotes T56	C0237849; Peeling of skin; Finding
T57	DISO 1166 1172	placas
#24	AnnotatorNotes T57	C0011389; Dental Plaque; Disease or Syndrome | C0332461; Plaque (lesion); Finding
T58	ANAT 1238 1258	pliegue suprapubiano
T59	ANAT 1260 1278	pliegue submamario
T60	ANAT 1282 1301	región sacrocoxígea
T61	Neg_cue 1305 1307	No
T62	DISO 1321 1339	lesiones satélites
T63	Negated 1321 1339	lesiones satélites
T64	ANAT 1353 1357	piel
#25	AnnotatorNotes T64	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T65	ANAT 1360 1366	anejos
T66	Neg_cue 1367 1369	no
T67	DISO 1380 1392	alteraciones
#26	AnnotatorNotes T67	C0012634; Disease; Disease or Syndrome
T68	Negated 1380 1392	alteraciones
T69	PROC 1396 1407	TRATAMIENTO
#27	AnnotatorNotes T69	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T70	PROC 1424 1475	Tratamiento tópico con corticoide de baja potencial
T71	Route 1436 1442	tópico
T72	Dose 1484 1494	aplicación
T73	Frequency 1495 1501	al día
T74	ANAT 1517 1521	zona
T75	Duration 1536 1547	dos semanas
T76	DISO 1568 1576	lesiones
#28	AnnotatorNotes T76	C0221198; Lesion; Finding | C3263723; Traumatic injury; Injury or Poisoning
T77	Neg_cue 1582 1585	sin
T78	Negated 1586 1605	resolución completa
T79	PROC 1614 1626	teleconsulta
#29	AnnotatorNotes T79	C0282675; Teleconsultation; Diagnostic Procedure
T80	PROC 1654 1672	tratamiento tópico
T81	Route 1666 1672	tópico
T82	CHEM 1677 1687	corticoide
#30	AnnotatorNotes T82	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T83	CHEM 1706 1716	clobetasol
#31	AnnotatorNotes T83	C0008992; clobetasol; Organic Chemical · Pharmacologic Substance
T84	Dose 1722 1741	una sola aplicación
T85	Frequency 1742 1748	diaria
T86	Duration 1757 1771	cuatro semanas
T87	DISO 1823 1833	dermatosis
#32	AnnotatorNotes T87	C0037274; Dermatologic disorders; Disease or Syndrome | C0178298; Skin and subcutaneous tissue disorders; Disease or Syndrome
T88	PROC 1837 1861	Terapia de mantenimiento
#33	AnnotatorNotes T88	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure
T89	PROC 1863 1881	tratamiento tópico
T90	Route 1875 1881	tópico
T91	CHEM 1889 1917	inhibidor de la calcineurina
T92	CHEM 1919 1931	pimecrolimús
#34	AnnotatorNotes T92	C1099414; pimecrolimus; Organic Chemical · Pharmacologic Substance
T93	Frequency 1952 1958	al día
T94	Duration 1967 1973	un mes
T95	Frequency 1992 2012	dos veces por semana
T96	Neg_cue 2014 2017	sin
T97	DISO 2018 2027	recidivas
#35	AnnotatorNotes T97	C2825055; Recurrence (disease attribute); Pathologic Function
T98	Negated 2018 2027	recidivas
T99	Date 2034 2051	el momento actual
T100	DISO 2079 2098	Psoriasis invertida
